A Study of Pembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)
Clinical trial NCT03976362 · COMPLETED
Trial details
- NCT number
- NCT03976362
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2023-09-21
- Enrollment
- 851
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.